https://www.selleckchem.com/products/ars-1620.html
0% vs 50.0%; p=0.031) and lower recurrence rates (8.5% vs 40.0%; p=0.002). TRα-positivity alone was not associated with any recurrence-free survival-related differences, and ERα- and TRα-negativity were associated with significantly shorter recurrence-free survival (p0.001). Enhanced ERα and TRα expression in breast cancer is associated with thyroid cancer occurrence, and the observed association with prognosis suggests the possible role of ERs and TRs in the link between breast cancer and thyroid cancer. Enhanced ERα and TRα expre
Like
Comment
Share
